Contact: +91-9711224068
  • Printed Journal
  • Indexed Journal
  • Refereed Journal
  • Peer Reviewed Journal
International Journal of Pharmaceutical Research and Development

Vol. 3, Issue 2, Part A (2021)

Roots and leaves extract from Ashwagandha plant uses in influenza virus and Indian traditional system of medicine

Author(s):

R B Singh

Abstract:

Withania somnifera Dunal (Ashwagandha) plant considered as an excellent Rasayana, health tonic and cure for a number of health complaints. Plants is a diuretic, sedative, anti-inflammatory, increasing energy and acts as an adaptogen that exerts a strong immunostimulatory and anti-stress agent. Ashwagandha plant taken for treating cold and coughs, ulcers, diabetes, leprosy, nervous disorders, rheumatism, arthiritis, intistinal infections, bronchitis, asthma, anticancer, HIV-AIDS, Influenza virus, Corona virus, covid-19 and TB patients. According to Indian herbal system of medicine, it is considered one of the most important herbs and best adaptogenic properties. Leaves extract are contains cuscohydrine, anahygrine, tropine, anaferine, aglycosides, withanolides, starch and amino acids. Withanolids alkoliods from roots and leaves consists of steroidal molecules to fight inflammation and stimulates the immune system, increases memory and helps maintain general health and wellness. Plant is known to increase the production of bone marrow and act anti-ageing, anti-tumor and anti-inflammatory agents. Its steroidal is much higher than that of hydrocarisone which is common treatment in cancer, TB, HIV, Influenza virus, Corona virus, Covid-19 and AIDS activity. It is also recognized as a blood tonic in gynacological disorders including anemia. Anxiety patients can also benefits from Ashwagandha roots and leaves extracts.

Pages: 23-25  |  1075 Views  448 Downloads


International Journal of Pharmaceutical Research and Development
How to cite this article:
R B Singh. Roots and leaves extract from Ashwagandha plant uses in influenza virus and Indian traditional system of medicine. Int. J. Pharm. Res. Dev. 2021;3(2):23-25. DOI: 10.33545/26646862.2021.v3.i2a.26
Call for book chapter